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Glycoprotein (G) of viral hemorrhagic septicemia virus (VHSV) and infectious hematopoietic necrosis virus (IHNV) contains
several neutralizing epitopes. However, recombinant G protein never matches intact viral particles for immunogenicity. DNA
immunization offers the possibility to deliver the antigen through the cellular machinery, thus mimicking natural infection. We
constructed pCDNA_gVHS and pCDNA_gIHN plasmids with the G gene of VHSV and IHNV under the control of the CMV
promoter, and we tested the plasmids for the accurate G protein expression prior to their use in fish immunization. Following
intramuscular injection to adult rainbow trout, plasmid DNA was found inside the muscle cells shortly after injection and was
still present 45 days later. mRNA of the G protein was detected in muscle tissue extracts, and the G protein was found within
muscle cells at the site of injection. This resulted in the synthesis of high levels of specific neutralizing and protective
antibodies. Fish injected with pCDNA_gVHS and pCDNA_gIHN in combination responded similarly to fish receiving one
recombinant plasmid. In addition to the elicitation of a strong humoral response, DNA immunization was able to activate
specialized cells of the immune system as well as nonspecific defense mechanisms, since mRNAs of MHC class II and Mx
were strongly activated at the site of injection. © 1998 Academic Press
INTRODUCTION
Viral hemorrhagic septicemia virus (VHSV) and infec-
tious hematopoietic necrosis virus (IHNV), are fish rhab-
doviruses which cause the most economically serious
viral diseases for the salmonid fish farming industry (de
Kinkelin et al., 1979; Wolf, 1988). Like other rhabdovi-
ruses, VHSV and IHNV have a unique transmembrane G
protein which is responsible for the attachment to the
cell membrane and the entry within the cell by a recep-
tor-mediated endocytosis (Lecocq-Xhonneux et al., 1994).
Neutralizing antibodies are exclusively directed against
the G protein and are the most important component of
the protective immune response against VHSV and IHNV
(Engelking and Leong, 1989; Lorenzen et al., 1990). The
gene coding for the G protein of several strains of VHSV
and IHNV has been cloned and sequenced (Koener et
al., 1987; Thiry et al., 1991; Lorenzen et al., 1993; Ben-
mansour et al., 1997). The expression in different plas-
mids and viral vectors was also obtained with the aim of
producing a subunit recombinant vaccine (Gilmore et al.,
1988; Koener et al., 1990; Lorenzen et al., 1993; Lecocq-
Xhonneux et al., 1994). Despite their antigenicity (Loren-
zen et al., 1993), the protective activity of recombinant G
proteins never matched that obtained with the intact
virus (Leong and Fryer, 1993; Lecocq-Xhonneux et al.,
1994). This led to questions about the role of the G
protein and the contribution of other viral proteins in the
induction of a protective immunity (Oberg et al., 1991).
Plasmid DNA immunization has been shown to induce
virus-specific neutralizing antibodies as well as strong
CTL responses in a variety of animal disease models
(reviewed in Donnelly et al., 1997). The utility of DNA
vaccination was also shown in fish (Anderson et al.,
1996a; Gomez-Chiari et al., 1996) with the demonstration
of a protective response against IHNV after injection of
plasmid DNA containing the G gene of IHNV (Anderson
et al., 1996b).
In many models, the efficiency of DNA immunization
was mostly attributed to the continuous and sustained
delivery of the antigen and to the early uptake of the
plasmid by professional antigen-presenting cells (APC).
The nature of these APC, especially those responsible
for CTL induction, is the object of active studies in the
mouse model (Doe et al., 1996; Huang et al., 1996) but is
largely unknown in the fish. The importance of cytokines
and costimulatory molecules in the adjustment of the
immune response following DNA immunization was
stressed in several reports (reviewed in Donnelly et al.,
1997), but the possibility of direct induction of nonspe-
cific components of the antiviral response by genetic
vaccination remains to be fully investigated.
In the present study, we efficiently immunized rainbow
trout (Oncorhynchus mykiss) with VHSV and IHNV glyco-
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protein DNAs, alone or in combination. To our knowledge
this is the first report of combined DNA immunization
against two different viral pathogens. We determined the
cellular localization of the plasmids and showed the
expression of the antigen in muscle and also in infiltrat-
ing cells. We also present evidence for the elicitation of
a highly protective humoral response accompanied by a
strong activation of specialized immunocompetent cells
and of components of the nonspecific antiviral response.
RESULTS
Plasmid construction and in vitro expression of
recombinant G proteins
The G gene of VHSV and IHNV, amplified by RT–PCR
from viral RNA, were directionally cloned into the EcoRI–
XhoI or HindIII–XhoI sites of plasmid pcDNA1, under the
control of the CMV IE promoter and SV40 polyadenyla-
tion sequences. The pCDNA_gRV containing the entire G
sequence of rabies virus was similarly constructed (kind-
ly provided by C. Tuffereau) and used in this study as a
nonrelevant control. To ensure that cloned G gene could
express G protein in vitro, the recombinant plasmids
were used as templates in the TNT coupled transcrip-
tion/translation system using the phage T7 DNA poly-
merase for transcription, rabbit reticulocyte lysate for
translation, and [35S]methionine for protein labelling.
Synthesized polypeptides were analyzed by SDS–PAGE
under denaturing conditions. The G protein of VHSV,
IHNV, and RV could be observed as monomers of ap-
proximately 56, 59, and 69 kDa, respectively (Fig. 1).
These values were consistent with the coding capacity of
each cloned sequence.
In vitro expression of recombinant G protein in
transfected cells
To ensure that the recombinant G protein could be
correctly processed by fish cells, 1 mg of pCDNA_gVHS
was transfected into semiconfluent RTG2 cells in the
presence of Genefect (Gibco BRL) according to the man-
ufacturer’s instructions. After 48-h incubation, permeabil-
ized and nonpermeabilized cell monolayers were sub-
jected to fluorescence detection using a murine mAb
specific for native G protein and fluorescein-labeled anti-
mouse Ig. The G protein could be seen as fluorescent
patches within the cytoplasm of permeabilized cells or
as a fine fluorescent lining on the plasma membrane in
nonpermeabilized cells (data not shown).
Uptake and persistence of plasmid DNA
To identify the cells that were transfected with pCD-
NA_gVHS, we performed direct in situ PCR on tissue
sections of muscle from DNA immunized fish from the
second series of experiments. For this purpose, bio-
tinylated direct and forward GVHS-specific primers
were synthesized and tested before use in liquid PCR
for amplification of the expected 260-bp fragment with
pCDNA_gVHS as template. The in situ PCR experi-
ments showed that at 7 and 28 days postinjection,
muscle cells at the site of injection were positive for
the presence of the GVHS gene sequence, which at a
high magnification appeared as dark-blue rounded
granulations within the muscle cells (Fig. 2A). Con-
trols, performed on identical tissue sections, but omit-
ting Taq polymerase or one specific primer, were neg-
ative for these granulations. Other controls, which
consisted of performing the complete in situ PCR re-
action on tissue sections from the muscle opposite to
the site of injection, were also negative (Fig. 2B). To
address the issue of persistence of the DNA within the
tissue, we performed liquid PCR with primers 3060
and 3061 on DNA extracted from a tissue specimen
taken at different time intervals. A DNA band of 1354
bp specific of the GVHS gene sequence was amplified
in liquid PCR on a muscle tissue extract on Days 7, 14,
21, and 45 postinjection (Fig. 3). No amplification was
obtained from nonrelevant tissue extracts.
In vivo transcription of recombinant G gene
To check that transcription of the recombinant G
gene was effective in injected muscles, we performed
a RT–PCR reaction on DNaseI-treated RNA from fish
injected with pCDNA-gVHS or the empty plasmid
pCDNA1. Amplification products of 293 bp were ob-
tained with primers 3060–2883 from muscle samples
taken at the site of injection 7, 14, or 21 days after
immunization with pCDNA-gVHS (Fig. 4B, lanes 1, 2, 5,
6, 9, and 10). To rule out template contamination with
plasmid DNA, a reverse-transcription reaction, in
which reverse-transcriptase was omitted, was run with
each DNaseI-treated RNA sample. No amplification
was observed in these controls, showing that PCR
products were amplified from cDNA (data not shown).
FIG. 1. In vitro coupled transcription/translation of recombinant G
genes used for DNA immunization. The major products of the de novo
protein synthesis from pCDNA_gVHSV (line 1), pCDNA_gIHNV (line 2),
and pCDNA_gRV (line 3) correspond to polypeptides of 56, 59, and 69
kDa, well in accordance with the coding capacity of the respective
cloned sequences.
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Similarly, no amplification was obtained from fish in-
jected with control pCDNA1 only (Fig. 4B, lanes 3, 4, 7,
8, 11, and 12). Actin mRNA amplification was per-
formed in each sample as a control of the total cDNA
amount (Fig. 4A). Hence, these results show that in
immunized fish, GVHS transcripts were present in the
muscle tissue at the site of injection.
In vivo expression of recombinant G protein
To assess the tissue and cell localization of the G
protein expression, muscle tissue sections from injected
and mock-injected fish were subjected to an indirect
immunoenzymatic test using a rabbit serum specific for
VHSV as a first antibody, biotinylated universal Ig anti-
FIG. 2. Detection of pCDNA_gVHS in muscle tissue by in situ PCR. (A) Section of muscle tissue from injected sites 21 days postinjection were
subjected to in situ PCR amplification with biotinylated primers. PCR products corresponding to the amplified G gene fragment were visualized with
alkaline phosphatase-labeled avidin and NBT-BCIP. They appear as dark-blue granulations (arrow) within myocytes (m). A negative control consisting
of in situ PCR performed on tissue sections from the contralateral muscle does not show these granulations (B). Bar, 20 mm.
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serum as a second antibody, and avidin-peroxidase (Vec-
tor) as a detector. The results show the presence of G
protein in tissue sections from the pCDNA_gVHS in-
jected fish, on Days 7, 14, and 21 postinjection (Fig. 5).
The G protein was inside the cytoplasm of muscle cells
(Fig. 5a), and at the periphery of muscle fibrils (Fig. 5b).
Cells infiltrating the tissue or lining vascular spaces were
also positively stained (Fig. 5c). Tissue sections from
pCDNA1 injected fish were negative for these inclusions.
Neutralizing and protective antibody synthesis in
immunized adult fish
Individual sera taken from injected fish of the first
series of experiments were tested for the presence of
specific VHSV and IHNV neutralizing antibodies. Figure 6
shows the kinetics of N-Ab synthesis for each group of
fish. With fish receiving three injections on Days 0, 23,
and 38, N-Ab against VHSV or IHNV were first detected
on Day 23 in a few fish, but on Day 38 all fish had
significant levels of N-Ab. The Ab response was highly
specific since there was no cross-reaction between sera
from fish injected with pCDNA-gVHS and those from fish
injected with pCDNA-gIHN. Similarly sera from fish re-
ceiving pCDNA-gRV did not neutralize VHSV or IHNV.
Interestingly, fish receiving a combination of pCDNA-
gVHS and pCDNA-gIHN developed a double-specific
N-Ab reaction whose kinetics and intensity were similar
to those observed with the single plasmid immunization.
Terminal sera from each group of fish were pooled to-
gether, titrated, and adjusted to a neutralizing titer of
1/1000. They were used in passive transfer to protect
naive juvenile trout from a subsequent lethal challenge
with VHSV or IHNV. As shown in Fig. 7, VHSV- and
IHNV-specific sera provided a 100% protection against
the corresponding virus, but sera from fish receiving
pCDNA-gRV did not afford a significant protection
against VHSV or IHNV.
DNA immunization activates Mx gene expression
Mx genes encode interferon-inducible proteins that
confer nonspecific resistance against viruses in different
mammalian species (Pavlovic et al., 1990; Schneider et
al., 1994; Frese et al., 1996). To reveal a potentiation of
nonspecific anti-viral defenses in fish after injection of
DNA vaccines, we searched for the expression of Mx
genes by a RT–PCR assay. Three rainbow trout Mx genes
have been cloned and sequenced (Trobridge and Leong,
1995; Trobridge et al., 1997). From conserved regions of
the published sequences, we devised a couple of for-
ward and reverse primers to amplify a 514-bp segment
from Mx genes. The specificity of the amplification was
confirmed by sequence determination on the purified
PCR product (data not shown). Our results show that
pCDNA_gVHS injection induces Mx transcription in the
muscle at the site of injection on Days 7, 14, and 21 after
immunization (Fig. 4C, lanes 1, 2, 5, 6, 9, and 10). Con-
versely, pCDNA1 injection did not induce any Mx expres-
sion (Fig. 4C, lanes 3, 4, 7, 8, 11, and 12). A nonspecific
antiviral mechanism is therefore activated by intramus-
cular DNA vaccine injection in rainbow trout.
DNA immunization activates MHC class II expression
As in mammals, fish class II molecules are presum-
ably expressed primarily by lymphoid/myeloid cells (Sult-
mann et al., 1993; Rodriguez et al., 1995), especially by
activated cells. To investigate whether pCDNA_gVHS
immunization induces the expression of class II mole-
cules at the site of injection, we used a RT-PCR assay
with specific primers amplifying MHC class II beta tran-
scripts. These PCR were performed on the same cDNA
samples used to investigate GVHS and Mx mRNAs. The
PCR results show that a DNA band of the expected size
was successfully amplified in samples from fish injected
with pCDNA_gVHS but not with pCDNA1 (Fig. 4D). The
sequence of the purified PCR product was determined to
confirm the specificity of the amplification (data not
FIG. 4. Expression of GVHS, Mx, and MHC class II transcripts at the
site of pCDNA_gVHS injection. (A) Actin mRNA was reverse transcribed
and amplified (247-bp product) from all samples as a control of cDNA
input. (B) Transcription of GVHS was investigated on Days 7, 14, and 21
after plasmid injection by a RT–PCR assay performed with primers
2883 and 3060 (giving a 293-bp product) on RNA extracted from muscle
tissue of fish injected with pCDNA_gVHS (lanes 1 and 2, 5 and 6, 9 and
10) or with pCDNA1 (lanes 3 and 4, 7 and 8, 11 and 12). The induction
of the transcription of Mx (C) and MHC class II beta gene (D) transcrip-
tion is illustrated from the same samples (the PCR products are at 514
and 594 bp, respectively).
FIG. 3. Detection pCDNA_gVHS in muscle extracts by liquid PCR.
PCR assay using primers 3060 and 3061 was performed on DNA
extracted from muscle samples taken on Days 7, 14, 21, and 45 after the
first injection of fish with pCDNA_gVHS (lanes 1, 3, 5, and 7) or pCDNA1
(lanes 2, 4, 6, and 8).
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shown). The expression of class II molecules on Day 7
postinjection strongly suggests that cells of the immune
system competent for the display of antigenic peptides
and for providing help to B cells are most probably
present at the site of injection.
DISCUSSION
We have successfully immunized rainbow trout with
plasmids expressing the mature G protein of VHSV and
IHNV. These results were a strong confirmation of the
determining contribution of the transmembrane glyco-
protein of two fish rhabdoviruses in conferring immunity
against a lethal challenge. Similar results were obtained
with rabies virus (Xiang et al., 1994), where the protective
activity of the G protein was shown to be mostly depen-
dent on the expression of the protein on the cell mem-
brane since constructs devoid of the anchoring se-
quence were less active (Xiang et al., 1995). It is likely
that the same would be true for the fish rhabdoviral
transmembrane glycoprotein. Although, we demon-
strated that the G protein of VHSV was expressed at the
surface of fish cells in vitro and in vivo, we cannot
exclude that secreted forms of the protein could have
contributed to the immunization. A highly specific protec-
tion was afforded by sera from fish immunized with the
corresponding gene but not by sera from fish immunized
with a nonrelevant gene. This is another indication that
protection against rhabdoviral diseases is mainly medi-
ated through neutralizing antibodies.
Immunization with viral genes was successfully dem-
onstrated in many animal models including fish (Don-
nelly et al., 1997; Anderson et al., 1996b), but this is the
first report of a highly efficient immunization against two
different viruses with combined DNA vaccination. Our
concern with combined immunization was the effect of a
prolonged delivery of two antigens on the rainbow trout
immune system, which is believed to have less reper-
toire diversity than that of mammals (du Pasquier, 1993).
As a matter of fact, the antibody reaction against each
antigen using a combined immunization was rather
equivalent in quality and intensity to that obtained with a
single immunization, considering the fish-to-fish variabil-
ity. This suggests that the fish immune system could
accommodate multiple antigens and open the way for
multipotent DNA vaccine preparations for fish.
An important issue in the DNA vaccination methodol-
ogy was the site of plasmid uptake and protein synthe-
sis. With plasmids injected intramuscularly, it is generally
admitted that the preferential site of plasmid uptake is
the muscle cell itself. Indeed, we clearly showed by in
situ PCR, that the recombinant gene was heavily incor-
porated within the cytoplasm and the muscle fibers.
Most authors agree on the site of plasmid uptake,
whereas the site of protein synthesis remains controver-
sial since the majority of reports fail to detect any syn-
thesized protein or report only quantities within the range
of the picogram (Wolff et al., 1988; Taubes, 1997). Al-
though we demonstrated that mRNA for the recombinant
FIG. 5. In vivo expression of GVHS at the site of injection. GVHs protein
was detected by an indirect immuno enzymatic assay in tissue sections
from the pCDNA_gVHS-injected fish on Days 7 (a), 14 (b), and 21 (c) after
injection. The G protein appeared as a red-brown reaction product inside
the cytoplasm of muscle cells and at the periphery of muscle fibrils (a) and
(b), in cells infiltrating the tissue or lining vascular spaces (c).
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gene was transcribed quantitatively and durably at the
site of injection, we only succeeded in detecting the
protein when we used fresh frozen tissue sections in
combination with a sensitive immunoenzymatic test. We
demonstrated that the protein was first present in the
cytoplasm and at the periphery of the muscle cells but
FIG. 6. Kinetics of neutralizing antibody synthesis in DNA immunized adult fish. Sera taken at Days 0, 23, 38, and 45 from individual fish were
assayed for neutralization of VHSV or IHNV using an end-point neutralization technique. Sera were serially diluted from 0 to 500. (a) Sera from
individual fish injected with pCDNA_gVHS tested for neutralization of 50 pfu of VHSV. (b) Sera from individual fish injected with pCDNA_gIHN tested
for neutralization of 50 pfu of IHNV. (c) Sera from individual fish injected with a combination of pCDNA_gVHS and pCDNA_gIHN tested for
neutralization of 50 pfu of VHSV. (d) Same sera as in (c) tested for neutralization of 50 pfu of IHNV.
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could be seen later in infiltrating cells and in endothelial
cells lining small capillaries. It seemed that protein pro-
duction could take place in different cells, allowing for
different compartments of the immune response to be
involved.
DNA immunization with GVHS and GIHN resulted in the
synthesis of significant amounts of specific neutralizing
antibodies, which implies that a strong and specific B
cell response was activated. Direct B cell activation nor-
mally takes place after extensive crosslinking of the B
surface-Ig by the antigen displayed in a repetitive motif;
otherwise, B cell activation needs T cell help. Native
rhabdoviral glycoproteins form a highly ordered structure
on the viral envelope and induce a very strong T-inde-
pendent B cell activation, while recombinant G proteins
need T cell help (Bachmann and Zinkernagel, 1996). A
direct B cell activation by GVHS after DNA vaccination
could then occur if the protein is expressed in a highly
organized epitopic structure at the surface of the trans-
fected cells. In fact, using immunocytochemistry we con-
firm the presence of GVHS at the periphery of muscle
cells. However, it is difficult to ascertain that the glyco-
protein was expressed at the cell surface in the proper
way to induce a direct B cell activation. Alternatively, by
analogy with the mammalian immune system, G-specific
B cells could be activated through G-specific T helper
cells. In mammals, sensitization of T cells needs two
signals, the first delivered by the MHC class II molecules
loaded with the peptide antigen and a second signal
from the accessory molecules only present on profes-
sional antigen presenting cells (APC). This process nor-
mally takes place in lymph nodes where antigen-loaded
APC encounter T cells. There are no lymph nodes in fish,
and efficient peptide presentation to T helper cells
should then take place in other lymphoid organs (Man-
ning, 1995). Muscle cells do not normally express class
II and accessory molecules, and they are unlikely stim-
ulators of T helper cells. Interestingly, we showed in this
work that DNA vaccination induced the expression of
MHC class II molecules at the site of injection, indicating
either the expression of class II molecules by muscle
cells or more likely the presence of immunocompetent
cells. We found that Mx was effectively induced at the
site of injection, signaling that a nonspecific response is
activated by DNA vaccination. This finding supports the
assumption of the presence of immunocompetent cells
at the site of injection since the recruitment of activated
immunocompetent cells is greatly enhanced by nonspe-
cific inflammatory mediators (Secombes et al., 1996).
Furthermore, Mx is well known as an antiviral interferon-
inducible protein in mammals (Pavlovic and Staeheli,
1991; Schneider et al., 1994; Frese et al., 1996), which
indicates that the efficiency of DNA immunization against
the two fish rhabdoviruses may also result from an early
nonspecific antiviral response.
Several reports have linked the high efficiency of DNA
immunization to the adjuvant effect of immunostimula-
tory sequences (ISS) present in bacterial DNA (reviewed
in Krieg et al., 1998). Since control plasmid without the G
gene failed to induce Mx and MHC class II expression in
our model, we can assume the ISS were probably not
playing a major role in the generation of a most efficient
immunization.
In conclusion, in this work we showed that (i) plasmids
recombinant for the G gene of two fish rhabdoviruses
express durably the recombinant protein at the site of
injection and are effective at inducing a strong protective
antibody response and (ii) efficiency of this mode of
immunization could be related to a direct B cell activa-
tion, an implementation of the protective B cell response
through T cell help, and the induction of a nonspecific
antiviral response.
MATERIALS AND METHODS
Plasmid construction and preparation
Recombinant pCDNA_gVHS and pCDNA_gIHN plas-
mids were constructed from the eukaryote expression
vector pCDNA1 (InVitroGen). Briefly, the G gene of VHSV
(variant tr25) (de Kinkelin et al., 1980) or IHNV (INRA
32–87) was reverse transcribed into cDNA from purified
viral RNA with MuLV reverse transcriptase (Gibco BRL).
The cDNA was subjected to PCR amplification with for-
ward and reverse primers containing restriction sites at
their 59 terminus (EcoRI and XhoI for VHSV, BamHI and
XhoI for IHNV). PCR products were double digested with
FIG. 7. Passive transfer of protection to naive juvenile fish. Day 45
sera from fish injected with pCDNA_gVHS or pCDNA_gIHN were sep-
arately pooled and titrated and their neutralization titer against the
corresponding virus adjusted to 1/1000. Terminal sera from fish in-
jected with pCDNA_gRV were similarly pooled. Four groups of 50
juvenile RBT each received 50 ml of pooled sera by intraperitoneal
injection. Groups 1 and 3 had RV serum, Group 2 had VHSV serum, and
Group 4 had IHNV serum. All groups were immediatly challenged by
the water route of infection. Groups 1 and 2 were challenged with
VHSV, Groups 3 and 4 with IHNV. Mortality was recorded daily and the
protective activity of the sera expressed as the percent survival after a
period of 15 days.
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the corresponding enzymes, purified by electrophoresis
on Nusieve GTG agarose, and inserted under the control
of the CMV promoter into a similarly restricted pCDNA1
vector. pCDNA_gRV, which contains the G gene of rabies
virus (strain CVS), was kindly provided by C. Tuffereau to
be used as a negative control. Plasmid DNA was purified
from lysed bacteria with Quiagen tip 1000 columns and
resuspended in PBS at 1 mg/ml DNA concentration.
In vitro translation of G proteins
The TNT coupled transcription/translation system
(Promega) was used to establish the fact that recombi-
nant G proteins of VHSV, IHNV, and RV can be expressed
in vitro. Each reaction mixture, containing rabbit reticu-
locyte lysate, T7 polymerase, amino acid mixture without
methionine, 0.8 mCi of [35S]methionine, 1 unit RNasin,
and 1 mg of pCDNA_gVHS, pCDNA_gIHN, or pCD-
NA_gRV, was incubated at 30°C for 90 min. After addition
of loading buffer and boiling for 3 min, the reaction
mixtures were subjected to discontinuous SDS–polyac-
rylamide gel electrophoresis and the de novo synthesis
visualized by autoradiography.
DNA immunization
In a first series of experiments, four groups of nine
adult fish, each weighing 150–200 g, were immunized
each by multipoint intramuscular injection with 30 mg in
100 ml DNA/fish of pCDNA_gVHS, pCDNA_gIHN, a mix-
ture of pCDNA_gVHS and pCDNA_gIHN or pCDNA_gRV.
Fish were injected deep in the muscle at equal distance
from the dorsal fin and the lateral line. Animals were
boosted twice on Days 23 and 38 with the same amount
of DNA. Fish were bled on Days 0, 23, 38, and 45. On Day
45, muscle samples (1 3 1 3 1 cm) were taken from
sacrificed fish at the site of injection for DNA extraction.
In a second series of experiments, a group of four fish
was injected intramuscularly with 30 mg of pCD-
NA_gVHS. Two fish were sacrificed on Day 7 and the
remaining fish on Day 28. Pieces of muscles at the site
of injection and at the contralateral site were taken and
processed for histology. In a third series of experiments,
two groups of six fish each were injected intramuscularly
with 30 mg DNA/fish of pCDNA_gVHS or the empty
plasmid pCDNA1. At 1-week intervals, two fish from each
group were anesthetized and sacrificed and the remain-
ing fish boosted. Uniform-sized (1 3 1 3 1 cm) pieces of
muscle tissue were taken from all sacrificed fish at the
site of injection. One part of the tissue was processed for
histology, and the other was immediatly frozen in liquid
nitrogen for DNA and RNA extraction.
DNA extraction from muscle tissue and PCR assay
Frozen muscle tissue was pulverized to powder in
liquid nitrogen and dissolved in 3 ml of lysis buffer (10
mM Tris-HCl, pH 8; 100 mM EDTA; 0.5% SDS; and 20
mg/ml RNase A), and the sample was incubated for 1 h
at 37°C. Proteinase K was added to 150 mg/ml, and the
sample was incubated at 60°C overnight. The digested
sample was extracted twice with phenol-chloroforme
(1:1) and once with chloroform-isoamyl alcohol (24:1).
DNA was precipitated from the aquous phase with 1
volume of isopropanol. The precipitate was pelleted by
centrifugation (30 min at 9000 g), washed with 70% eth-
anol, and dried at room temperature. The DNA pellet was
dissolved in 50 ml of TE buffer pH 8.3. DNA (5 ml) was
subjected to 45 cycles of 45 s at 94°C, 45 s at 55°C, 1
min at 72°C of PCR amplification with VHSV G specific
forward and reverse primers: 3060–59-GCGAATTCCAA-
GAGCACCACACCACAGAT-39 and 3061–59-CGCTCGA-
GTCTCAGTTGAATGACCAATCCGA-39, giving a 1354-bp
amplified fragment.
RNA extraction and RT-PCR assay
Total RNA was prepared from crushed muscle sam-
ples using the Trizol reagent (Life Technologies), then
treated with RNase-free DNaseI (Boehringer) to remove
all contaminant DNA. First-strand cDNA was synthesized
using a random primer p(DN)6 (Boehringer). Aliquots of
first-strand cDNA were subjected to PCR amplification
(94°C for 8 min followed by 25–30 cycles of 94°C for 1
min, 55°C for 1 min, 72°C for 2 min) with the following
primers: primers 3060 (see above) and 2883 (59-CAGGT-
GACTCGATAAGTCAC-39) to amplify a 293-bp fragment of
VHSV G, primers 5001 (59-TACATGATAGTCAAGTGCAG-
39) and 5002 (59-CCTGGGAGCTCCCTTCCACG-39) to am-
plify a 514-bp fragment of Mx, and primers 4021 (59-
TCAGATTCAACAGCACTGTGG-39) and 4023 (59-GTCT-
CACCTTGTTGCTACTAG-39) to amplify a 594-bp fragment
of MHC class II beta genes. Mx primers were devised
from region of complete homology within the three de-
scribed Mx genes of rainbow trout. All PCR reactions
were stopped in the exponential phase of amplification.
Actin mRNA was similarly amplified to assess that the
same amount of cDNA was used in all reactions. For this
purpose, rainbow trout actin gene was cloned and se-
quenced using primers corresponding to regions con-
served between carp, medaka, fugu, and human se-
quences. From this sequence, we derived two primers
specific for rainbow trout actin: 3094 (59-AGAGCTAT-
GAGCTGCCTGACGGAC-39) and 4003 (59-CAGGGCTGT-
GATCTCCTTCTGC-39) to amplify a 247-bp fragment of
the trout actin gene.
Plasmid localization by in situ PCR
Tissue preparation. Tissue blocks from the second
series of experiments were immersed for 3–5 days in
neutral Formalin, washed for 24 h in water, and then
dehydrated in graded ethanol. They were transferred to
xylene and embedded in paraffin. Six-micrometer tissue
sections from injected or noninjected muscle were pre-
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pared on PCR slides precoated with poly-L-lysine (Perkin-
Elmer). The sections were deparaffinized three times in
xylene for 3 min each and successively rehydrated in
ethanol/water. Permeabilisation of the cells was ob-
tained by treatment with 0.4% pepsin in 0.2 N HCl for 20
min. The sections were rinced twice with PBS, dehy-
drated in absolute ethanol and air dried at room temper-
ature.
In situ PCR. The PCR cocktail contained 1 mM biotin-
ylated primer, 200 mM deoxynucleotide triphosphate, 2.5
mM biotin-16dUTP, 3.5 mM MgCl2, 10 units Taq polymer-
ase in PCR reaction buffer II (Perkin-Elmer). Biotynilated
primers 3092 (59-ACGAGTACCCGTTCTTCCCT-39) and
3093 (59-CCTGGTGAACAGGTGTCCTT-39) were devised
to amplify a 260-bp fragment from the G gene of VHSV.
The PCR cocktail was warmed at 70°C for 5 min before
pipetting 50 ml onto the slide seated on the prewarmed
(70°C) mounting device (Perkin-Elmer). Cover slips and
chamber were mounted, and the slide transferred to the
in situ PCR 1000 apparatus (Perkin-Elmer) set for a soak
at 70°C. Cycling conditions were one cycle at 95°C for 2
min; 35 cycles of 94°C for 1 min, 55°C for 1 min, and
72°C for 2 min; one cycle at 72°C for 7 min and a 4°C
soak.
Biotin detection. After PCR, the chamber was disas-
sembled and the slide washed twice for 5 min in PBS.
Alkaline phosphatase-labeled avidin (Boehringer) diluted
1000-fold in Tris-HCl pH 7.6 was pipetted on the sample
and the slide incubated for 30 min at room temperature.
The slide was washed twice in Tris-HCl (pH 7.6), washed
twice in Tris-HCl (pH 9.4), and air dried. A solution of
NBT-BCIP in Tris-HCl (pH 9.4) was used to develop the
enzymatic reaction for 30–45 min in the dark. The slide
was extensively washed, mounted, and examined at high
magnification for presence of amplified DNA.
Protein detection by immunohistochemistry
Tissue preparation. Pieces of muscle tissue from fish
injected with pCDNA-gVHS or pCDNA1, to be tested for
G protein expression, were coated with Tissue-Tek
(Sakura), and immediately frozen at 280°C. Six micro-
meter tissue sections were prepared on slides pre-
coated with poly L-lysine. All operations were performed
at 221°C to preserve the native structure of the G pro-
tein. Slides were stored at 280°C until use.
Staining procedure. Tissue sections were fixed in cold
acetone for 10 min, rehydrated with PBS, and air dried at
room temperature. The Vectastain Universal Elite ABC kit
(Vector) was used for the staining of the tissue sections,
following the manufacturer’s instructions. This immuno-
peroxidase system employs an unlabeled primary anti-
body followed by a biotinylated secondary antibody and
then a preformed avidin and biotinylated horseradish
peroxidase complex. A rabbit serum specific for VHSV
obtained in our laboratory and diluted 1/500 in PBS was
used as the primary antibody. To localize the peroxidase
complex in the tissue sections, 3-amino-9-ethyl carba-
zole (AEC, Vector) was used as a chromogen. AEC pro-
duces a red-brown reaction product which contrasts with
the blue color of the rest of section, counterstained by
hematoxyline.
Seroneutralization
Seroneutralisations were performed by a simplified
end-point technique as described in Hattenberger et al.,
1989.
Seroprotection by passive transfer
Four groups of 50 fish each (rainbow trout alevins, 700
degreezday old) were injected intraperitonealy with 25
ml/fish of serum pooled from DNA-immunized fish. Group
1 received serum from fish injected with pCDNA_gVHS,
and Group 2 received serum from fish injected with
pCDNA_gIHN. The activity of each pooled specific serum
was determined and adjusted to neutralize 50 pfu of the
corresponding virus at 1/1000 dilution. Groups 3 and 4
received serum from fish injected with pCDNA_gRV.
Groups 1 and 3 were challenged by immersion for 3 h in
a suspension of 5.104 pfu/ml VHSV strain 07–71. Groups
2 and 4 were similarly challenged with 5.104 pfu/ml IHNV
strain 32–87. Fish were observed daily and mortality
recorded for a period of 2 weeks.
ACKNOWLEDGMENTS
This work was financially supported by the Institut National de la
Recherche Agronomique, France. Dr. M. Blanco is a recipient of a
postdoctoral fellowship of the Ministerio de Educacion y Cultura, Spain.
Dr. P. Boudinot is lecturer at the university of Paris XI, France. The
excellent technical assistance of Anne-Franc¸oise Monnier, Lucina
Abinne-Molza, Alexandra Leroux, Miche`le Danton (CNEVA, Alfort), and
Ghislaine Merle (CNEVA, Alfort) is gratefully acknowledged.
Note added in proof. During the revision of the manuscript, two
articles were published showing the usefulness of DNA vaccination
against VHSV (Heppell et al., 1998 and Lorenzen et al., 1998).
REFERENCES
Anderson, E. D., Mourich, D. V. and Leong, J. A. (1996a). Gene expres-
sion in rainbow trout (Oncorhynchus mykiss) following intramuscular
injection of DNA. Mol. Mar. Biol. Biotechnnol. 5, 105–113.
Anderson, E. D., Mourich, D. V., Fahrenkrug, S. C., LaPatra, S., Shep-
herd, J., and Leong, J. A. (1996b). Genetic immunization of rainbow
trout (Oncorhynchus mykiss) against infectious hematopoietic necro-
sis virus. Mol. Mar. Biol. Biotechnol. 5, 114–122.
Bachmann, M. F., and Zinkernagel, R. M. (1996). The influence of virus
structure on antibody responses and virus serotype formation. Im-
munol Today 17, 553–558.
Benmansour, A., Basurco, B., Monnier, A. F., Vende, P., Winton, J. R., and
de Kinkelin, P. (1997). Sequence variation of the glycoprotein gene
identifies three distinct lineages within field isolates of viral haem-
orrhagic septicaemia virus, a fish rhabdovirus. J. Gen. Virol. 78,
2837–2846.
de Kinkelin, P., Bearzotti Le Berre, M., and Bernard, J. (1980). Viral
305COMBINED DNA IMMUNIZATION AGAINST FISH RHABDOVIRUSES
septicemia of rainbow trout: Selection of a thermoresistant virus
variant and comparison of polypeptide synthesis with the wild-type
virus strain. J. Virol. 36, 652–658.
de Kinkelin, P., Chilmonczyk, S., Dorson, M., Le Berre, and M. Baudouy,
A. M. (1979). Some pathogenic facets of rhabdoviral infection of
salmonid fish. In ‘‘Munich Symposia of Microbiologia: Mechanisms of
Pathogenesis and Virulence,’’ pp. 357–375. WHO Center, Munich.
Donnelly, J. J., Ulmer, J. B., Shiver, J. W., and Liu, M. A. (1997). DNA
vaccines. Annu. Rev. Immunol. 15, 617–648.
Doe, B., Selby, M., Barnett, S., Baezinger, J., and Walker C. M., C. (1996).
Induction of cytotoxic T-lymphocytes by intramuscular immunization
with plasmid is facilitated by bone-marrow-derived cells. Proc. Natl.
Acad. Sci. USA 93, 8578–8583.
du Pasquier, L. (1993). Evolution of the immune system. In ‘‘Fundamen-
tal Immunology’’ (W. Paul, Ed.), pp. 199–228. Raven Press, New York.
Engelking, H. M., and Leong, J. A. (1989). The glycoprotein of infectious
hematopoietic necrosis virus elicits neutralizing antibody and pro-
tective responses. Virus Res. 13, 213–230.
Frese, M., Kochs, H., Feldmann, H., Hertkorn, C., and Haller, O. (1996).
Inhibition of bunyaviruses, phleboviruses, and hantaviruses by hu-
man MxA protein. J. Virol. 70, 915–923.
Gilmore, R. J., Engelking, H. M., Manning, D. S., and Leong, J. A. (1988).
Expression in Escherichia coli of an epitope of the glycoprotein of
infectious hematopoietic necrosis virus protects against viral chal-
lenge. BioTechnology 6, 295–300.
Gomez-Chiari, M., Livingston, S. K., Muro-Cacho, C., Sanders, S., and
Levine R. P. (1996). Introduction of foreign genes into the tissue of live
fish by direct injection and particle bombardment. Dis. Aquat. Org. 27,
5–12.
Hattenberger-Baudouy A. M., Danton, M., Merle, G., Torchy, C., and de
Kinkelin, P. (1989). Serological evidence of infectous hematopoietic
necrosis in rainbow trout from a french outbreak of disease. J. Aquat.
Anim. Health 1, 126–134.
Heppell, J., Lorenzen, N., Amstrong, N., Wu, T., Lorenzen, E., Einer-
Jensen, K., Schorr, J., Davis, H. L. (1998). Development of DNA
vaccines for fish: Vector design, intramuscular injection and antigen
expression using viral haemorrhagic septicaemia virus genes as
model. Fish Shellfish Immunol. 8, 271–287.
Huang, A. Y., Golumbec, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D. M.,
and Levitsky, H. (1996). Role of bone-marrow-derived cells in pre-
senting MHC class I-restricted tumor antigens. Science 264, 961–
965.
Koener, J. F., and Leong, J. A. (1990). Expression of the glycoprotein
gene from a fish rhabdovirus by using baculovirus vectors. J. Virol.
64, 428–430.
Koener, J. F., Passavant, C. W., Kurath, G., and Leong, J. (1987). Nucle-
otide sequence of a cDNA clone carrying the glycoprotein gene of
infectious hematopoietic necrosis virus, a fish rhabdovirus. J. Virol.
61, 1342–1349.
Krieg, A. M., Yi, A. K., Schorr, J., and Davis, H. L. (1998). The role of CpG
dinucleotides in DNA vaccines. Trends Microbiol. 6, 23–27.
Lecocq-Xhonneux, F., Thiry, M., Dheur, I., Rossius, M., Vanderheijden,
N., Martial, J., and de Kinkelin, P. (1994). A recombinant viral haem-
orrhagic septicaemia virus glycoprotein expressed in insect cells
induces protective immunity in rainbow trout. J. Gen. Virol. 75, 1579–
1587.
Leong, J. A., and Fryer J. L. (1993). Viral vaccines for aquaculture. In
0Annual Review of Fish Diseases,’’ Vol. 3, pp. 225–240. Pergamon
Press, New York.
Lorenzen, N. Lorenzen, E., Einer-Jensen, K., Heppell, J., Wu, T., Davis, H.
(1998). Protective immunity to VHS in Rainbow trout (Oncorhyncus
mykiss, Walbaum) following DNA vaccination. Fish Shellfish Immu-
nol. 8, 261–270.
Lorenzen, N., Olesen, N. J., and Jorgensen, P. E. (1990). Neutralization of
Egtved virus pathogenicity to cell cultures and fish by monoclonal
antibodies to the viral G protein. J. Gen. Virol. 71, 561–567.
Lorenzen, N., Olesen, N. J., Jorgensen, P. E., Etzerodt, M., Holtet, T. L.,
and Thogersen, H. C. (1993). Molecular cloning and expression in
Escherichia coli of the glycoprotein gene of VHS virus, and immuni-
zation of rainbow trout with the recombinant protein. J. Gen. Virol. 74,
623–630.
Manning, M. J. (1995). Fishes. In ‘‘Immmunology: A Comparative Ap-
proach’’ (R. J. Turner, Ed.), pp. 69–92. Wiley, Chichester.
Oberg, L. A., Wirkkula, J., Mourich, D., and Leong, J. C. (1991). Bacterially
expressed nucleoprotein of infectious hematopoietic necrosis virus
augments protective immunity induced by the glycoprotein vaccine
in fish. J. Virol. 65, 4486–4489.
Pavlovic, J., and Staeheli, P. (1991). The antiviral potentials of Mx
proteins. J. Interferon Res. 11, 215–219.
Pavlovic, J., Zurcher, T., Haller, O., and Staeheli, P. (1990). Resistance to
influenza virus and vesicular stomatitis virus conferred by expression
of human MxA protein. J. Virol. 64, 3370–3375.
Rodriguez, P. N., Hermsen, T. T., Rombout, J. H. W. M., Egberts, E., and
Stet, R. (1995). Detection of MHC class II transcripts in lymphoid
tissues of the common carp. Dev. Comp. Immunol. 19, 483–496.
Schneider, S. S., Schneider, S. J., Schuster, A., Bayer, M., Pavlovic, J.,
and M. V. (1994). Cell type-specific MxA-mediated inhibition of mea-
sles virus transcription in human brain cells. J. Virol. 68, 6910–6917.
Secombes, C. J., Hardie, L. J., and Daniels, G. (1996). Cytokines in fish:
A review. Fish Shellfish Immunol. 6, 291–304.
Sultmann, H., Mayer, W., Figueroa, F., O’Huigin, C., and Klein, J. (1993).
Zebrafish mhc class II a chain encoding Genes: Polymorphism ex-
pression and function. Immunogenetics 38, 408–428.
Taubes, G. (1997). Salvation in a snippet of DNA? Science 278, 1711–
1714.
Thiry, M., Lecocq-Xhonneux, F., Dheur, I., Renard, A., and de Kinkelin, P.
(1991). Sequence of a cDNA carrying the glycoprotein gene and part
of the matrix protein M2 gene of viral haemorrhagic scepticaemia
virus, a fish rhabdovirus. Biochim. Biophys. Acta 1090, 345–347.
Trobridge, G. D., Chiou, P. P., and Leong, J. A. (1997). Cloning of the
rainbow trout (Oncorhynchus mykiss) Mx2 and Mx3 cDNAs and
characterization of trout Mx protein expression in salmon cells.
J. Virol. 71, 5304–5311.
Trobridge, G. D., and Leong, J. A. (1995). Characterization of a rainbow
trout Mx gene. J. Interferon Cytokine Res. 15, 691–702.
Wolf, K. (1988). Viral hemorrhagic septicemia. In ‘‘Fish Viruses and Fish
Viral Diseases,’’ pp. 217–249. Cornell University Press, Ithaca, NY.
Wolff, J. A., Malone, R., Williams, P., Chong, W., Acsadi, G., Jani, A., and
Felgner, P. L. (1990). Direct gene tranfer into mouse muscle in vivo.
Science 247, 1465–1468.
Xiang, Z. Q., Spitalnik, S. L., Cheng, J., Erikson, J., Wojczyk, B., and Ertl,
H. C. (1995). Immune responses to nucleic acid vaccines to rabies
virus. Virology 209, 569–579.
Xiang, Z. Q., Spitalnik, S., Tran, M., Wunner, W. H., Cheng, J., and Ertl,
H. C. (1994). Vaccination with a plasmid vector carrying the rabies
virus glycoprotein gene induces protective immunity against rabies
virus. Virology 199, 132–140.
306 BOUDINOT ET AL.
